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Abstract
Because the defect in Cl- secretion exhibited by cystic fibrosis
(CF) epithelia reflects regulatory rather than conductive ab-
normalities of an apical membrane Cl- channel, we investi-
gated the role of different regulatory pathways in the activation
of Cl- secretion in freshly excised normal and CF nasal epithe-
lia mounted in Ussing chambers. A 8 agonist (isoproterenol
IISOI), a Ca2" ionophore (A23187), and a phorbol ester (PMA)
were all effective Cl- secretagogues in normal human nasal
epithelia. Agonist addition studies indicated that ISO and
PMA but not A23187 may share a common regulatory path-
way. In contrast, only A23187 induced Cl- secretion in CF
epithelia. Bradykinin raised cytosolic Ca2" and induced Cl-
secretion in both normal and CF tissues, indicating that recep-
tor gated Ca2" dependent Cl- secretory mechanisms were pre-
served in CF. The defective Cl- secretory response in CF epi-
thelia to ISO and PMA did not reflect abnormalities in
cAMP-dependent (A) and phospholipid Ca2"-dependent (C)
kinase activities. We conclude that (a) a Ca2"-sensitive mecha-
nism for regulating Cl- secretion is maintained in CF airway
epithelia, and (b) a regulatory pathway shared by two distinct
protein kinases is defective in CF, indicating that the CF ge-
netic lesion is not tightly coupled to a single (e.g., cAMP de-
pendent) regulatory mechanism.
Introduction
The defective C1- transport exhibited by cystic fibrosis (CF)'
airway epithelia reflects a defect(s) in regulatory processes
rather than the conduction properties of apical membrane Cl-
channels (1, 2). Most studies agree that normal but not CF cells
respond to agonists or cAMP-dependent kinase with activa-
tion of Cl- secretion or channels (1-6). However, because of
the difficulty in obtaining human tissues, a characterization of
other important regulatory pathways that control human air-
way Cl- secretion has not been reported. Widdicombe raised
the possibility that Ca2" ionophores function as Cl- secreta-
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1. Abbreviations used in this paper: BK, bradykinin; CF, cystic fibrosis;
D, diacylglycerol; HPETE, 15S-hydroperoxieicosa-5Z, 8Z, lIZ, 13E-
tetraneonic acid; IBMX, isobutyl methyl xanthine; I,,, short circuit
current; PKC, protein kinase C; PS, phosphatidylserine.
gogues in cultured CF airway epithelia (7). However, patch
clamp studies yielded conflicting results with respect to
whether cultured airway epithelia exhibit a Ca2l-dependent
mechanism for activation of Cl- channels (1, 2).
Therefore, the present study was undertaken with three
specific aims. First, employing pharmacologic agonists of dif-
ferent classes, we sought to characterize the important path-
ways, and their interactions, that control Cl- secretion in
freshly excised normal and CF airway epithelia. Secondly, we
tested whether Cl- secretion can be induced in CF epithelia by
both receptor-gated and ionophore-induced increases in cyto-
solic Ca2+. Thirdly, because of the absent Cl- secretory re-
sponse to both isoproterenol and PMA in CF, we compared
the form and activities of the intracellular enzymes that medi-
ate the actions of these agonists (cAMP-dependent protein ki-
nase [8] and protein kinase C [9]) in CF and normal cells.
Methods
Subjects
Nasal tissues were excised from 41 normal subjects (32±4 yr old); 22
males and 19 females were included. Tissues from all subjects were
obtained from the operating room, typically after general anesthesia.
The nasal polyps were excised from 16 cystic fibrosis patients (aged
14±5 yr; seven females, nine males). All CF patients had typical diag-
nostic clinical criteria for the disease and elevated sweat electrolytes.
Chemicals and solutions
Chemicals were obtained from the following sources. Hepes, brady-
kinin (BK) isoproterenol, PGE,, isobutyl methyl xanthine (IBMX),
and ampholines were obtained from Sigma Chemical Co., St. Louis,
MO. LTC4 and 15S-hydroperoxieicosa-5Z, 8Z, 1 1Z, 13E-tetraneonic
acid (15-HPETE) were obtained from Biomol, Plymouth Meeting, PA.
PMA and A23187 were obtained from Calbiochem-Behring Corp.,
San Diego, CA or Sigma Chemical Co. The acetoxymethylester of
Fura-2 (Fura-2/AM) was purchased from Molecular Probes, Eugene,
OR. Bumetanide was a gift of Leo Pharmaceuticals; amiloride was a
gift of Merck, Sharpe & Dohme, West Point, PA.
For bioelectric studies, a standard mammalian Krebs-Ringer bi-
carbonate buffer (KRB) was employed (3). For studies of intracellular
Ca2l levels, the NaCl Ringer contained the following (in millimolar):
150 NaCl, 2.5 K2HPO4, 1.0 CaCI2, 1.0 MgCl2, 5.0 glucose, and 10
Hepes, adjusted to pH 7.40 (37°C) with N-methyl-D-glucamine base.
In vitro bioelectric studies
Freshly excised specimens were mounted in Ussing chambers (0.25
cm2 [3, 10]), short-circuited, and exposed to amiloride (10-4 M, lu-
minal bath). The effects of log increasing additions of agonists (added
bilaterally every 3 min) on short circuit current (ISC) were tested. The
following agonists were tested in the ranges listed: A23187, 1i-9 to 3
X 10-6 M; PGE,, 10-" to 10-6 M; isoproterenol 10-9 to 10-5 M;
phorbol myristate acetate (PMA), 10-" to 10-6 M; leukotriene C4
(LTC4), 10-" to Il0` M; and 15-HPETE, 10-8 to 3 X 10-5 M. Because
tachyphylaxis was observed in preliminary studies with BK, as pre-
viously observed in canine trachea (1 1), a single maximal concentra-
tion ofBK (l0-5 M) was added to the mucosal surface. In some cases
after amiloride addition, a blocker of Cl- secretion (bumetanide,
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Figure 1. Changes in I,, in amiloride-pretreated (A) normal and (B)
CF nasal epithelia induced by addition of maximal effective concen-
trations of Cl- secretagogues of different pharmacologic classes. The
mean I,, of normal and CF tissues was 63±4 and 143±13 uA * cm-',
respectively before amiloride exposure and 26±3 and 5±3 ,A . cm-2
after amiloride, respectively. The half-maximal effective concentra-
tions (EC50) of agonists in normal tissues were as follows (M): isopro-
terenol (ISO), 5 X 10-8; A23187, 5 X l0-7; PMA, 10-9; LTC4, 10-9;
PGE1, l0-7; 15-HPETE, 10-6. The maximal effective concentrations
in normals were as follows (M): ISO, 10-6; A23187, 10-6; 15-
HPETE, 10-5; PGEI, l0-7; LTC4, 10-8; PMA, l0-7. The EC50 for
A23187 in CF tissues was 6 X l0-7 M; the maximal effective concen-
tration was 10-6 M. n denotes number of different patients.
Mean±SEM displayed.
10-4 M [12]) was added to the submucosal surface 30 min before
subsequent addition of A23187, BK, or PMA. Finally, cumulative
agonist addition experiments, employing maximal concentration(s) of
agonists, were performed in CF and normal tissues.
Cell culture
Cells from freshly excised nasal specimens were grown in an F- 12
hormone-supplemented medium as previously described (13) and
used 5-7 d after plating. The substrata employed in the cultures in-
cluded, as required, 35-mm plastic dishes, collagen matrices, and vit-
rogen-coated coverslips.
Loading cells with Fura 2 and cell chamber
Fura-2/AM was added to nasal cells grown on coverslips at a final
concentration of 2 ,M for 30 min at 370C. After loading, cells were
washed with NaCl Ringer and mounted in a chamber over the objec-
tive (UV-F X 100 glyc., NA 1.30, Nikon, Inc., Garden City, NY) of the
microscope (see below). Both chamber and objective were maintained
at 370C by a heat lamp (model 335, Opti-Quip, Inc., Highland Mills,
NY). The NaCI Ringer was prewarmed to 370C and exchanged fre-
quently (2-3 min; exchange time < 3 s) to remove any Fura-2 that
leaked from the cell.
Microspectrofluorimeter and measurements of [Ca]i
Measurements of [Ca]i in single nasal cells were obtained at 370C using
a fluorimeter system (Flurolog 2, model F2C, Spex Industries, Inc.,
Edison, NJ) attached to an inverted microscope (Nikon, Inc.). The
fluorescence from nasal cells was acquired alternately at 340 and 380
nm (emission 2 450 nm). A photometer was used to pass the fluores-
cence arising from each of the two excitation wavelengths from the
central region (spot diameter 5-10Om) of a single nasal cell.




















A23187 PMA ISO PMA A23187
ISO ISO PMA A23187 PMA
n-5 nwB n-3 n-5 n-5
B
Tm
ISO A23187 PMA ISO PMA A231B7
A23187 ISO ISO PMA A23187 PMAn-3 n-5 n-4 n-4 n-3 n-3
Figure 2. Changes in I,, of amiloride-pretreated (A) normal or (B)
CF tissues in response to cumulative agonist additions. The first ago-
nist added is listed as the first agonist under the abscissa and the re-
sponse is depicted as the change in current (±SEM) from 0. After the
maximal increase in Is, to the first agonist was obtained, the second
agonist was added in a cumulative fashion. The second agonist
added is listed underneath the first on the figure, and the change in
current in response to the second agonist is depicted as the mean in-
crement (±SEM of the increment) to the maximal response of the
first agonist. The component contributed by each agonist to the total
change in Ic is depicted by the shading contained in the bars.








cells and incomplete deesterfied Fura-2 were measured by exposing
cells to NaCl Ringer solution containing 10' M ionomycin and l0-3
M MnC12 (14). Background values obtained in this way were in good
agreement with values measured in unloaded cells. The background
signals were subtracted from the corresponding signals measured in
Fura 2-loaded cells before taking the ratio (340/380). The corrected
ratio was converted to [Ca]i using an external calibration standard and
the formula derived by Grynkiewiez et al. (15) for dual wavelength
measurements: [Ca]i = K (R, - Ro)/(R, - Rj, where Ro and R, are the
ratios at 0 Ca and saturating Ca, respectively. R, is the experimental
ratio. K represents Kd (Fol/F) where Kd (2.25 x l-' M at 370C) is the
effective dissociation constant for Fura-2, and F0 and F, are the fluores-
cence intensities at 380 nm (or 385 nm) minus and plus Ca, respec-
tively.
cAMP RIA
Cells were cultured on collagen matrices and grown to confluency.
Preliminary time course studies indicated that cAMP levels peaked
after a 10-min incubation with the agonists tested. A basal sample
(time 0) was obtained after which a 0-min incubation in F12 medium
containing the following agent(s) was carried out: isoproterenol (l0-5
M), forskolin (l0-5 M), PMA (l0-7 M), A23187 (10-6 M), IBMX (l0-5
M), PMA (l0-7 M) + IBMX (l0-5 M), isoproterenol (l0-5 M)
+ A23 187 (10-6 M), or vehicle (ethanol). The extraction and measure-
ment of cAMP was performed as described by Steiner et al. (16) as
previously described for this tissue (3).
Characterization ofcAMP-dependent kinase
Isolation ofcytosol. Cells were scraped from the plastic tissue culture
dishes, homogenized in a glass pestle in a homogenization solution (50
mM Hepes, pH 7.2; 0.25 M sucrose; 0.15 M NaCl; 10 mM MgCI2; 1
mM EDTA; 1 mM DTT; 20 mM benzamidine), and, after a low-speed
spin (300 g) to remove nuclei and large debris, cell membranes were
pelleted in an ultracentrifuge (100,000 g) and the supernatant (cytosol)
was harvested.
cAMP-dependent kinase assay. cAMP-dependent protein kinase
activities contained in the cytosolic fractions of normal and cystic
fibrosis cells were assayed by the technique ofGill and Walton (17). In
brief, aliquots of cytosol normalized for protein (40 gg per assay) were
incubated (assay volume of 50 Al) with magnesium (10 mM), buffer
] Normal
e CF
Banal PMA A23187 ISo Forskolin
10 min 10-7 10-6M 10-5 M 10- M
Figure 3. Intracellular cAMP concentrations of cultured normal and
CF nasal epithelial cells after 10-min exposure to putative Cl- secre-
tory agonists in concentrations listed below the agonist. Numbers of
0-min basal, PMA, A23187, ISO, forskolin for normal were 20, 12,
18, 10, and 5; for CF, 11, 4, 8, 8, and 4, respectively. The 0-min
basals were not significantly different from 0-min basals for NL (0-
min basal = 31.75±5.77, n = 20; 10-min basal = 38.21±6.19, n
= 20) or for CF (0-min basal = 26.63±5.72, n = 11; 10-min basal
= 25.66±5.46, n = 11). Asterisks indicate that the amounts ofcAMP
generated were significantly different from the 10-min basals.
5 W
(30 mM KH2PO4, 2 mM DTT), histone (Sigma Chemical Co. type
VII, I mg/ml), and IO-' M cAMP or vehicle (water). The reaction was
initiated with the addition of 10 MM [32P]ATP (3 MCi per tube) and
continued for 10 min at 30C after which 40 Ml ofthe reaction mixture
was pipetted onto filter paper (No. 3 M, Whatman Inc., Clifton, NJ)
and washed in 10% TCA (17).
Characterization ofisoforms ofcAMP-dependent kinase. Cytosolic
RI and RI, isozymes were separated and identified by their salt elution
profile (18) on a fast protein liquid chromotography/DEAE column
(LKB Products, Inc., Gaithersburg, MD) eluted using a 20 mM Tris-
HCl, I mM EDTA buffer (pH 7.4) with a linear 0-500 mM NaCl
gradient. Column fractions were assayed for kinase activity±10 AM
cAMP as described above.
Characterization ofprotein kinase C (PKC)
Measurement of whole-cell PKC activity. PKC activity of extracted
whole-cell homogenates of cystic fibrosis and normal cultured cells
were compared by the technique of Halsey et al. (19). Cells were ho-
mogenized in the buffer described above, the membrane-associated
PKC was extracted by incubation for 30 min at 0°C with 0.3% Triton
X-100, and a 100,000-g supernatant was prepared. Aliquots of the
supernatant (40 Mg of protein) were incubated with Mg2" (10 mM),
Tris (20 mM, pH 7.2), 20 MM [y-32p] ATP (5 MCi per assay), and a
fragment ofa lysine-rich histone (Sigma Chemical Co. type III-S) puri-
fied by HPLC after cleavage with N-bromosuccinimide (19). 32P incor-
poration for 10 min (30°C) without (basal) or with addition of Ca2l
(500 MM) or Ca2" plus 500 MM phosphatidylserine (PS) and 80 Mg of
diacylglycerol (D) was terminated when 40 Ml of the mixture was pi-
petted on filter paper (P-8 1, Whatman, Inc.) and washed in 10%
TCA (19).
Activation ofPKC in intact cells. Cultured normal and CF epithelial
cells were incubated in phosphate-free minimal essential medium with
0.5% fetal bovine serum containing 250 MCi of 32Pi for 4 h before each
experiment. PMA (l0-7 M) was added to the cultures for 10 min,
cultures were rinsed with phosphobuffered saline (pH 7.4) and the
incubation was stopped by adding electrophoresis buffer containing
9.5 M urea, 2% NP40, 2% ampholines (pH 3-10), and 5% fl-mercap-
toethanol. 25-Ml aliquots of sample were subjected to nonequilibrium
pH gradient electrophoresis followed by 10% PAGE in the second
dimension (20). Gels were dried and subjected to autoradiography on
AR film (Eastman Kodak Co., Rochester, NY).
Distribution ofPKC activity. Cytosol and membrane fractions were
prepared as above. The particulate fractions were solubilized with 0.3%
Triton X-100 and recentrifuged at 100,000 g for 30 min. The activities
of cytosol and solubilized particulates were measured using the stan-
dard PKC assay. In addition, to compare endogenous substrates in CF
and normal cells, cytosol and solubilized membrane fractions were
prepared as described above and incubated with [y-32P]ATP and with
or without the addition of PS, D, and Ca2". Aliquots were electro-
phoresed on one-dimensional 10% SDS-PAGE gels, stained with Coo-
massie blue, destained, dried, and subjected to autoradiography.
Results
The nasal epithelial C1- secretory response to potential C1-
secretagogues (1, 2, 21-25) was measured as the change in ISC
in tissues pretreated with amiloride to abolish the component
ofactive Na+ absorption to the ISC (3, 7). In normal tissues (Fig.
1 A), isoproterenol and A23187 were equieffective. PMA, an
activator ofPKC (9), routinely induced Cl- secretion but was
less effective, as reported in canine trachea (24, 25). The ara-
chidonic acid metabolites, LTC4, PGEI, and 1 5-HPETE, were
less effective than A23187. Previous studies have shown that
the increased I,, of amiloride pretreated normal tissues in re-
sponse to such agonists, e.g., isoproterenol or PGEI, is paral-
leled by an increase in the isotopically measured secretory flux
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Table I. Change in Cell Ca2+ Levels and Isc Induced by BK (10S- M) in Amiloride (O0-i M)-pretreated Normal and CF Tissues
Normal (n = 4) CF (n = 4)
Before During A Before During A
Cell Ca2, nM 115±10 506±32 391±26* 118±12 515±51 397±43*
A I., A .cm-2 13.2±2.5 25.2±2.6 12.0±.5* 2.4±2.0 19.2±6.8 16.8±6.3*
Data expressed as mean±SE. * Different from zero (P < .05).
of Cl-, and that this C1- secretory current is partially inhibited
by bumetanide (3). In the present study, bumetanide pretreat-
ment (10-4 M) inhibited 65% of the response to A23187 in
normal tissues (AI,, of bumetanide pretreated tissues in re-
sponse to A23187 = 7.2±3 ,A * cm-2, n = 4), indicating this
change in Ik, also reflects C1- secretion. Bumetanide pretreat-
ment inhibited a similar fraction of the PMA induced I,,
(70±8%; n = 3).
In contrast to normal tissues, only A23187 raised I,, in
amiloride pretreated CF tissues (Fig. 1 B). The A23187-in-
duced response in CF differed from normals in that the maxi-
mal increase was smaller (- 60% of the AIs, in normals) and
the effect was shorter in duration. Cl- secretion could be in-
duced in CF tissues bathed on the mucosal surface with a
Ringer solution with 500 nM Ca2l and exposed to mucosal
A23187. This observation indicates that unphysiological levels
of cytosolic Ca2' may not be required to induce Cl- secretion
(also see Table I). The increase in Ih, induced by A23187 in CF
tissues was partially inhibited by bumetanide pretreatment
(62% inhibition; AIsh = 4.6±0.1 uA cm-2, n = 4), indicating
that at least a major fraction of the stimulated I,, reflects the
induction of chloride secretion.
Studies of drug interactions with the Cl- secretory path
were performed in normal nasal epithelia with cumulative ad-
ditions of maximal effective agonist concentrations (Fig. 2 A).
Isoproterenol, added during the maximal sustained (5 min)
effect of A23187, routinely further increased the Cl- current;
A23187 also routinely added to the maximal sustained effect
induced by isoproterenol. Similarly, A23187 added to the C1-
current induced by maximal effective concentrations ofPMA,
and PMA added to the maximal response induced by A23187.
In contrast, isoproterenol added to the maximal effect induced
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isoproterenol. Consequently, whereas fully additive effects
were not observed between A23187 and isoproterenol or
PMA, the highly reproducible increment in Is, after A23187
addition to isoproterenol or PMA prestimulated tissues indi-
cates that components of the Ca2+-dependent pathway(s) are
separate from the isoproterenol- and/or PMA-dependent path.
In CF, no combination of PMA or isoproterenol with
A23187 induced a larger response than A23187 alone (Fig. 2
B). The combination of PMA and isoproterenol was ineffec-
tive.
The interactions between these agonists were explored at
the level of cAMP accumulation. As shown in Fig. 3, isopro-
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Figure 5. Ic tracings for (A) normal and (B) CF nasal epithelia.
Amiloride (10-5 M, mucosal surface [M]) and bradykinin (10- M,
mucosal surface [M]) were added cumulatively at times noted.
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Figure 6. cAMP-dependent protein kinase activity of cytosol from
normal and cystic fibrosis cultured nasal epithelial cells. Enzyme ac
tivity is expressed as picomole of P04 transferred to substrate per
milligram of protein per minute. N reflects number of natient sam-
ples. The mean±SEM is shown.
mutation in normal cells. A23187 induced smaller but signif
cant changes in cell cAMP concentrations. PMA did not do
tectably alter cell cAMP levels, as previously observed i
canine trachea (24, 25). No systematic difference in respons(
to these agonists was observed between normal and CF cells
Additional studies revealed that addition of IBMX,
phosphodiesterase inhibitor, increased basal cAMP concei
trations but did not reveal a PMA-induced increment i
cAMP for normal (IBMX, 137.46±22.32 pmol/mg prn
tein; IBMX plus PMA, 101.93+21.02 pmol/mg protein) or C
(IBMX, 53.01±19.75 pmol/mg protein; IBMX plus PM}
40.4±23.97 pmol/mg protein) cells. Further, no additivity i
cell cAMP concentrations was detected comparing incubatic
with A23187 and isoproterenol to isoproterenol alone in C
(isoproterenol, 421.22±51.87 pmol/mg protein; isoproteren(
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Figure 7. DEAE chromatographed isoforms of cytosolic cAMP-de-
pendent kinase in (A) normal and (B) CF cells. The activity in the
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Figure 8. PKC activity of homogenates extracted with 0.3% Triton
X-100 from normal and cystic fibrosis cultured nasal epithelial cells.
Enzyme activity in the presence or absence of PS, D, and Ca2" is ex-
pressed as picomole of P04 transferred to substrate per milligram of
protein per minute. N reflects number of patient samples.
Mean±SEM is shown.
in proterenol, 418.73±85.87 pmol/mg protein; isoproterenol
°- plus A23187, 536.34±49.11 pmol/mg protein) cells.
F These findings may have implications with regard to path-
A, ways that control the rate of Cl- secretion in human airway
in epithelia. First, because PMA does not raise cAMP concentra-
in tions, the effect of PMA is clearly not mediated by cAMP. In
F addition, the additive effects ofisoproterenol and PMA are not
1ol due to any additive effect on cAMP accumulation. Secondly,
>°~ because little additivity in cellular cAMP concentrations was
detected with A23187 and isoproterenol, the additivity ob-
served for these two agonists with respect to rates of Cl- secre-
tion observed also is not likely to be a consequence of the level
of cellular cAMP.
To test whether the activation of Cl- secretion induced by
the calcium ionophore A23187 is mimicked by receptor-gated
increases in cytosolic Ca2", intracellular Ca2+ levels and I., of
amiloride-pretreated tissues were measured before and after
exposure to BK ([I0-' M], Table I). No differences in basal
Ca2+ levels between CF and normals were noted, as previously
reported (26). BK-induced rapid rises (Fig. 4) in intracellular
Ca2" levels that were not different in CF and normal (Table I).
The response ofthe IC to BK administration is shown in Fig. 5
and summarized in Table I. In amiloride-pretreated tissues,
BK induces a rapid increase in ISc with a variable plateau
phase. Pretreatment with bumetanide inhibited the maximal
BK-induced change in IC by 65% to 74% in normal and CF
tissues, respectively.
The defect in CF Cl- secretion in response to isoproterenol
and PMA was further explored by measuring the maximal
stimulated activities of protein kinase activities of cells cul-
tured from CF and normal subjects. Fig. 6 shows that the
cAMP-dependent kinase activity ofcytosolic fractions was not
different in CF and normal cells. When DEAE chromatogra-
phy was used to analyze the holoenzyme isotypes in CF and

























C r-Cytosol --IrSol. part.
++
NL CF NL CF






Figure 9. Phosphorylation of endogenous substrates from subcellular fractions of normal and CF-cultured respiratory epithelial cells. Autoradi-
ography was performed after gel electrophoresis of fractions phosphorylated in the presence or absence of PS, D, and Ca2+. (A) Autoradiograph
of phosphorylated cytosolic proteins; (B) autoradiograph of phosphorylated solubilized particulate fraction; (C) the Coomassie blue staining
pattern of the gel shown in A and B. The arrow points to prominent PKC-dependent substrates.
normal, the type II (RI, containing) isoform of the cAMP-de-
pendent kinase was the dominant isoform in both CF and
normal cells (Fig. 7).
We next tested whether total PKC activity differed in CF
and normal cells. Total cell PKC activity, measured at maxi-
mally stimulating concentrations of PS and D (18) after quan-
titative extraction of homogenates with 0.3% Triton X-100,
was not different in CF and normal cells (Fig. 8). Further,
fractionation of PKC activity into cytosolic and detergent ex-
tractable particulate fractions showed that > 80% of the basal
activity resided in the cytosolic compartment in both CF and
normal cells.
Endogenous substrates in the cytosol and extracted mem-
brane fractions were studied in the absence and,presence ofPS,
-TPA +TPA
D, and Ca2'. The radioautograph of the phosphorylated cyto-
solic and solubilized membrane fractions from CF and normal
cells is shown in Fig. 9. Two substrates, - 43 and - 30 kD,
were phosphorylated in both CF and normal cells to the same
extent upon the addition ofactivators ofPKC. The solubilized
particulate fractions were devoid ofdetectable PKC substrates.
To obtain a measure ofPKC activity in intact normal and
CF cells, cells were labeled for 4 h in phosphate-free media
with 32p;. Endogenous substrate phosphorylation was then as-
sessed after 10 min in control and PMA-treated cells. Two
substrates were detected in the 35-40- and 1 7-20-kD region of
the gel. The pI of the substrates was 6.2 and 9.0, respec-
tively. Equivalent phosphorylation of each substrate was seen














Figure 10. Nonequilibrium pH gradient and PAGE of.32Pi-labeled
intact CF and normal cultured cells treated for 10 min with or with-
out PMA (l0-7 M). Arrows demonstrate two substrates that were
phosphorylated in a PMA-dependent manner in both (A) CF and (B)
normal cells. The - 34-40-kD substrate has a pI of 6.2 and a
17-20-kD substrate has a pI of 9.0.
In normal human airway epithelia, agonists that raise cytosolic
Cal' or that activate cAMP-dependent protein kinase (isopro-
terenol) or PKC (PMA) induce Cl- secretion. In contrast, only
a Ca2'-dependent C1- secretory mechanism appears functional
in freshly excised CF nasal epithelia (7, 27). Double-barreled
Cl- microelectrode experiments have pinpointed the locus of
action of Ca2+ ionophores in both normal and CF airway epi-
thelia to the apical membrane Cl- conductance (28). Unfortu-
nately, neither the data cited above nor those presented in this
paper elucidate the mode(s) of the A23 187 activation of apical
membrane Cl- channels in human respiratory epithelia. How-
ever, the addition both of the first product (1 5-HPETE) pro-
duced via the major arachidonic acid metabolic pathway in
human epithelial cells (15-lipoxygenase [29]) and other eico-
sanoids (PGEI, LTC4) failed to induce chloride secretion in CF
tissues. This finding indicates that, unlike the canine trachea
(23), the A23187-induced activation of Cl- secretion in CF
tissues probably is not mediated by effects on AA metabolism.
A key finding in this study is that CP- secretion (Fig. 5,
Table I) can be induced in CF tissues by BK receptor gated
Pattern ofCystic Fibrosis Secretagogue Response 1429
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increases in cytosolic Ca2" (Fig. 4). These findings indicate that
(a) the coupling mechanisms, presumably inositol trisphos-
phate mediated, for receptor activation and increases in cyto-
solic Ca2" activities are intact in CF cells and (b) that receptor-
gated increases in Ca2" levels are equieffective in initiating Cl-
secretion in CF and normal cells. This finding consequently
provides an important physiologic control for the specificity of
action of calcium ionophore responses. Like the actions of
A23187, the mechanism ofactivation ofCl- secretion by BK is
not clear. However, the failure ofexogenous additions ofPMA
or eicosanoids to initiate Cl- secretion in CF tissues makes it
likely that BK-induced increases in cell Ca2" levels are working
through a mechanism that does not involve activation ofPKC
or phospholipase A2, respectively.
As previously shown in fresh tissue (4, 30) and cultured
cells (2, 26), the failure ofCF tissues to respond to C1- secreta-
gogues of the beta adrenergic class is not due to a failure to
produce cAMP. The data in Fig. 6 confirm the report of
Berthelson and Widdicombe (31) that cytosolic A kinase in CF
and normal cells exhibits the same maximal activity in the
presence of exogenous cAMP. In addition, the data in Fig. 7
indicate that the RI, isoform ofthe A kinase dominates in both
CF and normal airway epithelia. The observation that the RI,
isoform is expressed in airway epithelia suggest that this form,
which is often associated with the plasma membrane, is pres-
ent in respiratory epithelial cells. Preliminary patch clamp
data indicate that cAMP plus ATP can activate Cl- channels in
off cell patches of airway epithelium, consistent with the no-
tion that some kinase is membrane associated (32).
A second key finding in this study is that the PKC system
appears to have a role in the activation of Cl- secretion in
normal human tissues but is ineffective in inducing Cl- secre-
tion in CF tissues. Whereas PKC isoforms were not compared
in CF and normal airway epithelia, several types of experi-
ments indicate that total PKC activity is similar in CF and
normals. Assays of total cell PKC activity do not detect a
difference in maximal activity between CF and normal tissues
(Fig. 8). Our experiments also indicate that the distribution of
basal PKC activity in cytosol (> 80% of activity) and mem-
brane fractions are equivalent, as is the ability to phosphory-
late endogenous substrates in cell-free assays (Fig. 9). Lastly,
the capacity of PMA to activate PKC in intact cells also is
similar in CF and normal cells (Fig. 10). Thus, it appears that
whereas normal tissues develop Cl- secretion in response to
the activation oftwo independent kinases (A kinase, C kinase),
CF tissues, despite apparently normal kinase activities, do not.
The finding that activation of C kinase is ineffective in
initiating Cl- secretion in CF epithelia indicates that the acti-
vation defect in CF is not limited to the A kinase path. This
finding increases the complexity of the CF regulatory defect,
but suggests that proteins whose state of phosphorylation is
governed by both A and C kinase can be considered important
targets when searching for differences in CF and normal phos-
phoprotein profiles.
Our data suggest a complex mechanism of regulation for
Cl- secretion in human airway epithelia with at least two dis-
tinct pathways. First, agents that activate A and C protein
kinases appear to work via a common path that converges
upon a regulatory protein(s) whose activity is altered by phos-
phorylation. The lack of efficacy of both isoproterenol and
PMA in CF, and the failure of the two agents to act additively
in normals, lend support to this concept. Secondly, evidence
for a distinct calcium-dependent path is derived from the ad-
ditivity of A23 187 and isoproterenol or PMA in normals, and
the retention of A23 187 efficacy in CF tissues.
The retention of the Ca2l but not cAMP-dependent path
for secretion in airways appears to mimic the pattern observed
in the CF sweat gland wherein the cholinergic (Ca2"-mediated)
but not f3-adrenergic (cAMP-mediated) path is effective in ini-
tiating sweat formation, presumably through a Cl- secretory
mechanism (30). The recent report that Ca2" ionophores and
carbachol are ineffective in the CF small intestine (33) indi-
cates retention of Ca2+-dependent mechanisms for Cl- secre-
tion may not be a uniform feature ofCF epithelium. However,
the finding that increases in cell Ca2+ levels are effective ini-
tiating Cl- secretion in CF airway epithelia does raise the possi-
bility that this mechanism may be therapeutically exploited in
the future. Specifically, agents that raise cell Ca2W levels, via
direct or receptor-mediated actions, may effectively initiate
Cl- and water fluxes toward the airway lumen.
Acknowledgments
The authors thank Ruth Dy and Nell Burch for expert technical assis-
tance and Lisa Brown for editorial assistance.
This study was supported by National Institutes of Health grant 5
PO1 HL-34322-04 and Cystic Fibrosis Foundation grant RO 15 9-C2.
References
1. Frizzell, R. A., G. Rechkemmer, and R. L. Shoemaker. 1986.
Altered regulation of airway epithelial cell chloride channels in cystic
fibrosis. Science (Wash. DC). 233:558-560.
2. Welsh, M. J., and C. M. Liedtke. 1986. Chloride and potassium
channels in cystic fibrosis airway epithelia. Nature (Lond.). 322:467-
470.
3. Boucher, R. C., M. J. Stutts, M. R. Knowles, L. Cantley, and
J. T. Gatzy. 1986. Na+ transport in cystic fibrosis respiratory epithelia:
abnormal basal rate and response to adenylate cyclase activation. J.
Clin. Invest. 78:1245-1252.
4. Boucher, R. C., C. U. Cotton, J. T. Gatzy, M. R. Knowles, and
J. R. Yankaskas. 1988. Evidence for reduced C1- permeability and
increased Na+ permeability in cystic fibrosis human primary cell cul-
tures. J. Physiol. (Lond.). 405:77-103.
5. Shoumacher, R. A., R. L. Shoemaker, D. R. Halm, E. A. Tallant,
R. W. Wallace, and R. A. Frizzell. 1987. Phosphorylation fails to
activate chloride channels from cystic fibrosis airway cells. Nature
(Lond.). 330:752-754.
6. Li, M., J. D. McCann, C. M. Liedke, A. C. Nairn, P. Greengard,
and M. J. Welsh. 1988. Cyclic AMP-dependent protein kinase opens
chloride channels in normal but not cystic fibrosis airway epithelium.
Nature (Lond.). 331:358-360.
7. Widdicombe, J. H. 1986. Cystic fibrosis and beta-adrenergic
response of airway epithelial cell cultures. Am. J. Physiol. 251 :R818-
R822.
8. Greengard, P. 1978. Phosphorylated proteins as physiological
effectors. Science (Wash. DC). 199:146.
9. Nishizuka, Y. 1984. Turnover of inositol phospholipids and
signal transduction. Science (Wash. DC). 225:1365.
10. Knowles, M. R., M. J. Stutts, A. Spock, N. Fischer, J. T. Gatzy,
and R. C. Boucher. 1983. Abnormal ion permeation through cystic
fibrosis respiratory epithelium. Science (Wash. DC). 221:1067-1070.
11. Leikauf, G. D., I. F. Ueki, J. A. Nadel, and J. H. Widdicombe.
1985. Bradykinin stimulates chloride secretion and prostaglandin E2
release by canine tracheal epithelium. Am. J. Physiol. (Renal Fluid
Electrolyte Physiol.). 248:F48-F55.
1430 Boucher et al.
12. Widdicombe, J. H., J. T. Nathanson, and E. Highland. 1983.
Effect of loop diuretics on ion transport by dog tracheal epithelium.
Am. J. Physiol. 245:388-396.
13. Wu, R., J. Yankaskas, E. Cheng, M. R., Knowles, and R.
Boucher. 1985. Growth and differentiation of human nasal epithelial
cells in culture. Serum-free, hormone-supplemented medium and
proteoglycan synthesis. Am. Rev. Respir. Dis. 132:311-320.
14. Tsien, R. Y. 1989. Fluorescent probes of cell signaling. Annu.
Rev. Neurosci. 12:227-253.
15. Grynkiewicz, G., M. Poenie, and R. Y. Tsien. 1985. A new
generation ofCa indicators with greatly improved fluorescence proper-
ties. J. Biol. Chem. 260:3440-3450.
16. Steiner, A. L., C. W. Parker, and D. M. Kipnis. 1972. Radioim-
munoassay for cyclic nucleotides. J. Biol. Chem. 247:1106-1113.
17. Gill, G. M., and G. M. Walton. 1979. Assays in protein kinases.
Adv. Cyclic Nucleotide Res. 10:93.
18. Corbin, J. D., S. L. Keely, and C. R. Park. 1975. The distribu-
tion and dissociation of cyclic adenosine 3':5'-monophosphate-depen-
dent protein kinases in adipose, cardiac, and other tissues. J. Biol.
Chem. 250:218-225.
19. Halsey, D. L., P. R. Girard, J. F. Kuo, and P. J. Blackshear.
1987. Protein kinase C in fibroblasts: characteristics of its intracellular
location during growth and after exposure to phorbol ester and other
mitogens. J. Biol. Chem. 262:1234.
20. O'Farrell, P. Z., H. M. Goodman, and P. H. O'Farrell. 1977.
High resolution two-dimensional electrophoresis of basic as well as
acidic proteins. Cell. 12:1133-1142.
21. Al-Bazzaz, F. J., and G. Cheng. 1979. Effect of catecholamines
on ion transport in dog tracheal epithelium. Appl. Physiol. 47:397.
22. Al-Bazzaz, F. J., and T. Jayaram. 1981. Ion transport by canine
tracheal mucosa: effect ofelevation ofcellular calcium. Exp. LungRes.
2:121.
23. Al-Bazzaz, F. J., and V. Yadava. 1984. Ion transport in dog
tracheal mucosa: interaction between extracellular calcium and prosta-
glandins. Am. J. Physiol. 297:C182.
24. Barthelson, R. A., D. B. Jacoby, and J. H. Widdicombe. 1987.
Regulation of chloride secretion in dog tracheal epithelium by protein
kinase C. Am. J. Physiol. (Cell). 22:C802-C808.
25. Welsh, M. J. 1987. Effect of phorbol ester and calcium iono-
phore on choride secretion in dog tracheal epithelium by protein ki-
nase C. Am. J. Physiol. (Cell). 22:C828-C834.
26. Murphy, E., E. Cheng, J. Yankaskas, M. J. Stutts, and R. C.
Boucher. 1988. Cell calcium levels of normal and cystic fibrosis nasal
epithelium. Pediatr. Res. 24:79-84.
27. Case, M. 1986. Chloride ions and cystic fibrosis. Nature
(Lond.). 322:407.
28. Willumsen, N. J., and R. C. Boucher. 1989. Activation of an
apical Cl- conductance by Ca2+ ionophores in cystic fibrosis airway
epithelia. Am. J. Physiol. 256:C226-C233.
29. Hunter, J. A., W. E. Finkbeiner, J. A. Nadel, E. J. Goetzl, and
M. J. Holtzman. 1985. Predominant generation of 15-lipoxygenase
metabolites ofarachidonic acid by epithelial cells from human trachea.
Proc. Nail. Acad. Sci. USA. 82:4633-4637.
30. Sato, K., and F. Sato. 1984. Defective beta adrenergic response
of cystic fibrosis sweat glands in vivo and in vitro. J. Clin. Invest.
73:1763-1771.
31. Barthelson, R., and J. Widdicombe. 1987. Cyclic adenosine
monophosphate-dependent kinases in cystic fibrosis tracheal epithe-
lium. J. Clin. Invest. 80:1749-1802.
32. Stutts, M. J., E. Cheng, H. S. Earp, M. R. Knowles, J. R.
Yankaskas, and R. C. Boucher. 1987. cAMP dependent activation of
Cl- channels in airway epithelial cells. Pediatr. Pulmonol. 3(Suppl.
1):1 16. (Abstr.)
33. Berschneider, H. M., M. R. Knowles, R. G. Azizkhan, R. C.
Boucher, N. A. Tobey, R. C. Orlando, and D. W. Powell. 1988. Altered
intestinal chloride transport in cystic fibrosis. FASEB. (Fed. Am. Soc.
Exp. Biol.) J. 2:2625-2629.
Pattern ofCystic Fibrosis Secretagogue Response 1431
